A study by Kuchenbaecker et al. showed that breast cancer PRSs are predictive of cancer risk in BRCA1 and BRCA2 carriers and that the incorporation of a PRS into risk prediction models better informs decisions on cancer risk management and increased the accuracy of risk estimation for individuals who inherit an MPV [64]. This evidence concerns the gene BRCA2 and breast carcinoma.